Abbasi, A., Peeke, S., Shah, N., Mustafa, J., Khatun, F., Lombardo, A., . . . Bachier-Rodriguez, L. (2020). Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis. J Hematol Oncol.
Chicago Style CitationAbbasi, Ahmed, et al. "Axicabtagene Ciloleucel CD19 CAR-T Cell Therapy Results in High Rates of Systemic and Neurologic Remissions in Ten Patients With Refractory Large B Cell Lymphoma Including Two With HIV and Viral Hepatitis." J Hematol Oncol 2020.
Cita MLAAbbasi, Ahmed, et al. "Axicabtagene Ciloleucel CD19 CAR-T Cell Therapy Results in High Rates of Systemic and Neurologic Remissions in Ten Patients With Refractory Large B Cell Lymphoma Including Two With HIV and Viral Hepatitis." J Hematol Oncol 2020.